Cytalux 3.2 mg/1.6 mL (2 mg/mL) injection Images
Generic Name: pafolacianine
This medication has been identified as Cytalux 3.2 mg/1.6 mL (2 mg/mL) injection. It is supplied by On Target Laboratories, Inc.
Cytalux is used in the treatment of Diagnosis and Investigation and belongs to the drug class malignancy photosensitizers. Cytalux 3.2 mg/1.6 mL (2 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Cytalux
- Generic Name
- pafolacianine
- Strength
- 3.2 mg/1.6 mL (2 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Malignancy photosensitizers
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- On Target Laboratories, Inc.
- National Drug Code (NDC)
- 81052-0138
See also:
Lexiscan
Lexiscan is used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging ...
Baqsimi
Baqsimi is used to treat very low blood sugar (severe hypoglycemia) in adults and children aged 1 ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Gvoke
Gvoke is used subcutaneously to treat very low blood sugar (severe hypoglycemia) in people with ...
Regadenoson
Regadenoson is used for diagnosis and investigation, radionuclide myocardial perfusion study
Gadobutrol
Gadobutrol is used for CNS Magnetic Resonance Imaging, diagnosis and investigation, vascular ...
Arginine
Arginine is used for diagnosis and investigation, dietary supplementation
More about Cytalux (pafolacianine)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: malignancy photosensitizers
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.